Accelerate Diagnostics (AXDX)
(Delayed Data from NSDQ)
$0.95 USD
+0.01 (1.54%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $0.91 -0.04 (-3.73%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.95 USD
+0.01 (1.54%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $0.91 -0.04 (-3.73%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Zacks News
Becton (BDX) with FlowJo to Provide Cloud Platform Services
by Zacks Equity Research
Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has entered into an agreement with FlowJo, LLC.
Mead Johnson-Reckitt Move to Merge, Deal Closes on Jun 15
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) and Reckitt Benckiser have cleared the final regulatory hurdle of their impending merger.
PetMed Express' New Order Sales Increase, Competition Rife
by Zacks Equity Research
On Jun 12, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).
Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space
by Zacks Equity Research
Quest Diagnostics (DGX) recently announced agreements to acquire two laboratory businesses in Lewisville, Texas, namely Med Fusion and Clear Point.
Phibro Animal Health (PAHC) Rides High on Solid Prospects
by Zacks Equity Research
On Jun 12, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) ??? a leading global diversified animal health and mineral nutrition company.
Luminex's (LMNX) VERIGENE Panels Receive Approval in Japan
by Zacks Equity Research
Luminex Corporation (LMNX) recently announced that Japan's Central Social Insurance Medical Council has approved to provide reimbursement for VERIGENE assays.
Will Walgreens-Rite Aid Deal Fall Flat on FTC Blockade?
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) stock took a marginal hit of 0.6% on Friday's close, following the news breakout that the FTC is blocking the impending Rite Aid merger deal.
Masimo (MASI) Presents Utility Study of Oxygen Reserve Index
by Zacks Equity Research
Masimo Corporation (MASI) recently announced data from its study evaluating the potential clinical utility of Masimo Oxygen Reserve Index.
NuVasive (NUVA) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of NuVasive, Inc. (NUVA) scaled a new 52-week high of $81.06 on Jun 9, eventually closing a bit lower at $79.13.
Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3
by Zacks Equity Research
Share price of Cardiovascular Systems, Inc. (CSII) scaled a new 52-week high of $32.68 on Jun 9, eventually closing a bit lower at $30.93.
Medtronic Launches MiniMed 670G to Better Manage Diabetes
by Zacks Equity Research
Medtronic plc (MDT) commercially launched MiniMed 670G system, a Hybrid Closed Loop insulin delivery system for Type I diabetic patients.
Invacare (IVC) Prices $105 Million Convertible Senior Notes
by Zacks Equity Research
Invacare Corporation (IVC) recently announced that it has priced convertible senior notes worth $105 million.
CVS Health Gains on Pharmacy Services, Strategic Buyouts
by Zacks Equity Research
On Jun 8, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).
Hologic Wins FDA Approval for Genius 3D Mammography Exam
by Zacks Equity Research
Hologic, Inc. (HOLX) continues to expand its Breast and Skeletal Health business through innovation and product development.
Zimmer Biomet Rides on Spine Business, Knee Challenges Stay
by Zacks Equity Research
On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).
Bruker Grows on NMR & Nano Businesses amid Several Odds
by Zacks Equity Research
On Jun 6, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR), a manufacturer of proprietary life science and materials research systems.
Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)
by Zacks Equity Research
Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.
Cardiovascular Systems Innovation On Track, Competition Rife
by Zacks Equity Research
On Jun 6, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).
Medtronic SureTune3 Obtains Health Canada License for DBS
by Zacks Equity Research
Medtronic plc (MDT) recently announced the receipt of Health Canada license for SureTune 3 software for deep brain stimulation (DBS).
Boston Scientific Wins CE Mark for Vercise Gevia DBS System
by Zacks Equity Research
Boston Scientific Corporation (BSX) recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System.
HealthEquity (HQY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity Inc (HQY) reported earnings of 19 cents per share in the first quarter of fiscal 2018, higher than the Zacks Consensus Estimate of 16 cents.
Amedisys (AMED) Prospects Impressive Amid Tough Competition
by Zacks Equity Research
On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).
Abiomed (ABMD) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Abiomed, Inc. (ABMD), scaled a new 52-week high of $142.95 on Jun 5, eventually closing a bit lower at $141.81.
Cerner (CERN) to Develop Electronic Health Records System
by Zacks Equity Research
Cerner Corp (CERN) recently announced that it has been chosen by the U.S. Department of Veterans Affairs to develop an electronic health record (EHR) system.
Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).